If the sperm itself is defective, no intervention can fix it
For the millions of couples who have faced infertility without explanation, science has long offered incomplete answers. Now, researchers in Hyderabad have identified eight genes whose mutations silently disrupt the making of sperm — passed from mothers who never feel their effect to sons who bear their full consequence. The discovery, drawn from two decades of work and the genetic analysis of thousands of men, does not merely name a cause; it offers couples the rare gift of knowing what is possible.
- In roughly 60% of male infertility cases in India, the cause has remained entirely unknown — a silence that has left couples cycling through treatments with no map and no guarantee.
- Eight newly identified genes, including Centrine 1, can disrupt cell division itself when mutated, quietly dismantling the biological machinery that produces sperm.
- These mutations travel an invisible path — inherited from mothers who carry them without consequence, they surface only in sons, making them easy to miss and historically impossible to screen for.
- A study of over 2,000 men confirmed the pattern holds: these eight genes appear consistently in infertile men and may explain 12% of cases involving insufficient sperm production.
- Genetic screening tests can now be updated to detect these mutations before treatment begins, sparing couples from interventions that cannot work and pointing those who can benefit toward the right path.
Infertility touches one in seven couples worldwide, and in roughly half those cases the problem originates with the man. For decades, researchers understood some causes — chromosomal abnormalities, mitochondrial mutations, environmental factors — but in about six out of ten male infertility cases in India, the cause remained simply unknown. Scientists at Hyderabad's Centre for Cellular and Molecular Biology have spent two decades trying to close that gap.
Led by K. Thangaraj, now director of the DBT-Centre for DNA Fingerprinting and Diagnostics, the team began by sequencing roughly 30,000 genes in 47 infertile men whose condition had no identified cause. Eight genes emerged as candidates. To confirm the signal, they expanded their analysis to more than 1,000 fertile and 1,000 infertile men across India — and the pattern held. Published in Human Molecular Genetics, the findings suggest these eight genes may account for roughly 12% of cases involving insufficient sperm production, with seventeen distinct variants identified across them.
One of the genes, Centrine 1, sits on chromosome 18 and disrupts the very machinery of cell division when mutated. What makes the discovery especially significant is its inheritance pattern: these genes pass from mother to son, remaining dormant in women while potentially devastating sperm production in men.
The practical implications are immediate. Genetic screening can now identify men who carry these mutations before treatment begins — revealing whether assisted reproduction techniques like IVF have any realistic chance of success. For couples navigating infertility, the shift from mystery to mechanism offers something rare and valuable: clarity, and with it, the possibility of more honest and effective paths forward.
Infertility touches one in seven couples worldwide, and in roughly half of those cases, the problem originates with the man. For decades, researchers have understood some of the reasons—chromosomal abnormalities, mitochondrial mutations, environmental factors. But a stubborn gap remained: in about six out of every ten cases of male infertility in India, the cause was simply unknown. Now, scientists working in Hyderabad have begun to close that gap.
Researchers at the Centre for Cellular and Molecular Biology have spent two decades chasing the genetic roots of male infertility. Their earlier work had already mapped out the landscape: roughly 29 percent of infertile men carry deletions or rearrangements on the Y chromosome. Another 9 percent show mutations in mitochondrial or autosomal DNA. That still left the majority of cases unexplained. K Thangaraj, who led the new research and now directs the DBT-Centre for DNA Fingerprinting and Diagnostics, decided to look harder.
The team began by sequencing roughly 30,000 genes in 47 infertile men whose infertility had no identified genetic or environmental cause. From that initial sample, they identified eight genes that appeared to be mutated in ways that might explain the men's condition. To test whether this signal was real, they expanded their search dramatically, analyzing genetic material from more than 1,000 fertile men and more than 1,000 infertile men across India. The pattern held. The eight genes showed up consistently in the infertile men's samples.
One of these genes, called Centrine 1, sits on chromosome 18. When mutated, it disrupts the machinery of cell division itself—the process that generates sperm. The researchers found seventeen distinct variants across the eight genes, suggesting multiple pathways to the same outcome: insufficient sperm production. The work, published in Human Molecular Genetics, suggests these eight genes may account for roughly 12 percent of cases where men produce too little sperm.
What makes the discovery particularly useful is its inheritance pattern. Thangaraj explained that these genes pass from mother to son. In women, they remain silent, causing no apparent effect. In men, they can wreak havoc on sperm production. This means genetic screening can now identify which men carry these mutations—and crucially, it can tell couples whether assisted reproduction techniques like in vitro fertilization might actually work. If the sperm itself is defective at the genetic level, no amount of laboratory intervention can fix it. But if the mutation is identified early, couples can make informed decisions about their options.
The implications ripple outward. Genetic screening tests can now be updated to include these eight genes, transforming how clinicians approach male infertility. Instead of cycling through expensive treatments that have no chance of working, couples can know upfront whether their situation is amenable to intervention. The research also opens doors to developing better management strategies tailored to the specific genetic cause. For the millions of couples navigating infertility, this shift from mystery to mechanism offers something precious: clarity, and with it, the possibility of more effective paths forward.
Citações Notáveis
These genes are passed from mothers to sons and remain dormant in women, probably affecting only sperm production in sons— K Thangaraj, lead investigator and Director of DBT-Centre for DNA Fingerprinting and Diagnostics
The identified genes can now be added to screening tests to determine whether assisted reproduction can help a couple— Research findings, as reported by the Centre for Cellular and Molecular Biology
A Conversa do Hearth Outra perspectiva sobre a história
Why did it take so long to find these genes? Weren't researchers looking?
They were looking, but the search space is enormous. You have to sequence thousands of genes in hundreds of people to spot a pattern. The technology to do that affordably is relatively recent. And you need large comparison groups—fertile men to contrast against infertile men—to know if a mutation actually matters.
So these genes were always there, just invisible until now?
Exactly. The mutations existed in these men's DNA the whole time. But without a systematic way to read 30,000 genes at once and compare them across populations, there was no way to connect the mutation to the problem.
The fact that women carry these genes but don't get sick from them—that's strange, isn't it?
It is. It suggests these genes do something very specific to sperm production, something that doesn't have an equivalent in female reproduction. Or maybe women's biology has a backup system that men's doesn't. We don't fully understand why yet.
If a couple finds out the man has one of these mutations, what actually changes for them?
Everything, potentially. If the mutation is confirmed, they know assisted reproduction won't help. That saves them years of treatment and enormous expense. They can pivot to other options—adoption, donor sperm, or accepting childlessness. The clarity itself is valuable.
Does finding the gene mean you can fix it?
Not yet. This research is about diagnosis and prognosis, not treatment. But once you know which genes cause the problem, you have a target. Future research might develop ways to correct the mutation or compensate for it. For now, the value is in knowing what you're dealing with.